JS

Jill P. Smith

PS Penn State: 5 patents #117 of 1,788Top 7%
GU Georgetown University: 4 patents #75 of 501Top 15%
CA Cancer Advances: 3 patents #2 of 14Top 15%
📍 Camp Hill, PA: #6 of 145 inventorsTop 5%
🗺 Pennsylvania: #4,155 of 74,527 inventorsTop 6%
Overall (All Time): #263,354 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
12251364 Treating non-alcoholic steatohepatitis with cck inhibitors 2025-03-18
12150978 Compositions and methods for preventing tumors and cancer Lynda Sutton, Allen Cato, Teresa Phillips 2024-11-26
12076383 Compositions and methods for inducing humoral and cellular immunities against tumors and cancer Lynda Sutton, Nicholas Osborne, Brian E. Huber, Allen Cato 2024-09-03
11696922 Nanoparticle to target cancer Stephan Stern, Abdullah Mahmud 2023-07-11
11583576 Compositions and methods for inducing humoral and cellular immunities against tumors and cancer Lynda Sutton, Nicholas Osborne, Brian E. Huber, Allen Cato 2023-02-21
11278551 Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor Louis M. Weiner, Sandra Jablonski, Sandeep NADELLA, Shangzi Wang 2022-03-22
11246881 Nanoparticle to target cancer Stephan Stern, Abdullah Mahmud 2022-02-15
10668126 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor Ian S. Zagon, Patricia J. McLaughlin 2020-06-02
9562095 Method for treating tumors that possess the CCK-C receptor with the 3B9.1 monoclonal antibody 2017-02-07
9375458 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor Ian S. Zagon, Patricia J. McLaughlin 2016-06-28
9149544 Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo Thomas T. Morgan, Brian M. Barth, James H. Adair, Rahul Sharma, Mark Kester +5 more 2015-10-06
8889640 Composition and method for the treatment of gastrin mediated cancers Mark Kester, Gail L. Matters, John F. Harms 2014-11-18
8821872 Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer Gail L. Matters, Neil Christensen, John F. Harms 2014-09-02
8003630 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor Ian S. Zagon, Patricia J. McLaughlin 2011-08-23
7879870 Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists Ian S. Zagon, Moshe Rogosnitzky 2011-02-01
6737397 Control of cancer growth through the interaction of [MET5]-enkephalin and the zeta receptor Ian S. Zagon, Patricia J. McLaughlin 2004-05-18
5849800 Use of amantadine for treatment of Hepatitis C 1998-12-15